Mark Chin - Former Director at Pyxis Oncology, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Former Director
Stock Symbol
PYXS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark Chin since 10/5/2023

Holdings reported by Mark Chin for Pyxis Oncology, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to buy) 42.2K $162K $3.83 Oct 7, 2021 Direct Common Stock
Common Stock 0 $1.40 Apr 21, 2022 Indirect
Series B Convertible Preferred Stock 0 Oct 13, 2021 Indirect Common Stock

Transactions reported by Mark Chin for Pyxis Oncology, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.